Antiviral Solutions

Genekam Biotechnology AG has developed a number of solutions and molecules, which can be used to inhibit the Ebola infections in order to create new therapies. These molecules can be sourced from us and laboratories around the world can conduct the research studies e.g. preclinical and clinical to demostrate that these molecules can inhibit the Ebola viruses. Not only this, we are trying to develop more molecules to inhibit the Middle east Respiratory syndrome viruses infections (SARS virus), dengue viruses, Influenza viruses as well as animal viruses like Foot and mouth disease etc.

Genekam has developed two different systems to create the molecules, which have potential to be used as therapies one day:

These molecules offer the new chances to many laboratories around the world to conduct the research in the field of therapies. Much of research work can be conducted and published as Master or Ph.D. thesis or reseach paper. These molecules are being offered to any laboratory around the world to conduct world class research in the field of therapeutic or inhibiting the viral pathogens. The above said molecules can be used to inhibit the viruses in human and animals i.e. if they have potential to be used for human and veterinary medicine one day.

2.1 Genekam-T-001 A molecule against Ebola virus	10 reactions	call
2.2 Genekam-T-002 A molecule against Ebola virus	10 reactions	call
2.3 Genekam-T-003 A molecule against Ebola virus	10 reactions	call
2.4 Genekam-T-004 A molecule against Ebola virus	10 reactions	call
2.5 Genekam-T-005 A molecule against Ebola virus	10 reactions	call
2.6 Genekam-T-006 A molecule against Ebola virus	10 reactions	call
2.7 Genekam-T-007 A molecule against Ebola virus	10 reactions	call
2.8 Genekam-T-008 A molecule against MERS virus	10 reactions	call (available within 2 weeks)
2.9 Genekam-T-009 A molecule against MERS virus	10 reactions	call (available within 2 weeks)
2.10 Genekam-T-010 A molecule against MERS virus	10 reactions	call (available within 2-3 weeks)
2.11 Genekam-T-011 A molecule against Foot and mouth disease (FMD)	10 reactions	call (available 4-8 weeks or later)

Please work with us for these molecules. If there will be successful with the research of such molecules, applications of these molecules may change the ways to generate the new therapies in future.

Liste of therapeutic Molecules (Genekam):

	Therapeutic Molecules	Stage 1 (Development)	Stage 2 (In vitro studies)
TM1	Activin A receptor II
TM2	Dengue Virus 2 -Version 1	passed
TM3	Dengue Virus 2 -Version 2	passed
TM4	Dengue Virus 2 -Version 3	passed
TM5	Dengue Virus 2 -Version 4	passed
TM6	Ebolavirus – Version 1	passed
TM7	Ebolavirus -Version 2	passed
TM8	Epstein Barr Virus	passed
TM9	H5N1 Neuraminidase	passed
TM10	H5N1 Matrix	passed
TM11	H5N1 Hemagglutinin	passed
TM12	Human Polyomavirus -Version 1	passed
TM13	Human Polyomavirus -Version 2	passed
TM14	Human Papillomavirus 16	passed
TM15	Human Papillomavirus 5	passed
TM16	Human CD38 -Version 1	passed
TM17	Human CD38 -Version 2	passed
TM18	Human CD27	passed
TM19	Human CD19	passed
TM20	Japanese Encephalitis Virus	passed
TM21	Middle East Respiratory Syndrom (MERS	passed
Z103	Porphyromonas gingivalis	passed
TM22	Rabies (Lyssavirus rabies)	passed
TM23	Rift Valley Fever Virus	passed
TM24	TNF alfa	passed
TM21	Wuhan Corona	passed
Z101, Z102	Zika Virus	passed	passed